Investing.com - Tabula Rasa HealthCare (NASDAQ: TRHC) reported first quarter EPS of $-0.63, $0.39 worse than the analyst estimate of $-0.24. Revenue for the quarter came in at $88.3M versus the consensus estimate of $82.79M.
Guidance
Tabula Rasa HealthCare sees FY 2023 revenue of $355.00M-$365.00M
Tabula Rasa HealthCare's stock price closed at $5.26. It is down -13.20% in the last 3 months and up 34.87% in the last 12 months.
Tabula Rasa HealthCare saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Tabula Rasa HealthCare's stock price’s past reactions to earnings here.
According to InvestingPro, Tabula Rasa HealthCare's Financial Health score is "fair performance".
Check out Tabula Rasa HealthCare's recent earnings performance, and Tabula Rasa HealthCare's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar